Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 26.65
-0.53 (-1.95%)
Apr 29, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.38 billion as of April 29, 2026. Its market cap has increased by 16.89% in one year.
Market Cap
5.38B
Enterprise Value
5.12B
Revenue
1.74B
Ranking
n/a
PE Ratio
18.81
Stock Price
26.65
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.38B, a decrease of -21.32%. That is a compound annual growth rate of -4.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Biotest Biotech | 5.33B |
| ChemPartner PharmaTech | 5.26B |
| Beijing Scitop Bio-tech | 5.59B |
| Beijing Konruns Pharmaceutical | 5.61B |
| Jiangsu Bioperfectus Technologies | 5.11B |
| Kexing Biopharm | 5.68B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.68B |
| Novogene | 5.73B |